SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, which focuses on the development of bacteriophage therapeutics for the treatment of drug-resistant bacterial infections. The company was founded in 1989 and is headquartered in Los Angeles, CA.

Armata Pharmaceuticals Inc

Armata Pharmaceuticals ($ARMP) is trending after releasing positive Phase 2a study results for its AP-SA02 bacteriophage cocktail, showing high cure rates for Staphylococcus aureus bacteremia. The community is excited about the potential of AP-SA02 becoming a new standard of care, with some anticipating a rise to double-digit price levels, while others suggest an offering might be on the horizon.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors debate a recent pullback despite news of a significant hyperscaler deal; the lack of a named partner in the deal is fueling speculation and uncertainty, while some community members point to broader market factors and sector rotation as potential causes for the price action.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

Applied DNA Sciences ($BNBX) is trending due to a recently closed private placement of up to $58 million, intended to fund a BNB-focused digital asset treasury strategy. The community is actively discussing the company's shift towards cryptocurrency, the potential for a short squeeze given the low float, and comparing it to other similar plays. Some traders express concerns about dilution and the timing of the news release, while others remain optimistic about the company's new direction and the involvement of strategic advisors like Anthony Scaramucci.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors discuss potential catalysts, including upcoming earnings and the possibility of securing a "Golden Dome" contract.  Community talking points range from anticipating a short squeeze to analyzing fund activity and overall market sentiment.  Bullish investors suggest buying the dip in anticipation of positive news, while bears cite valuation concerns.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending downwards following an earnings report that missed estimates due to a one-time tax charge in Brazil, sparking concerns about profitability and valuation among investors. Community discussions revolve around whether the dip is an overreaction and a buying opportunity, or a sign of deeper issues like slowing subscriber growth and increasing competition. Some are also citing cultural concerns related to content.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending downwards, sparking intense debate among investors about its future. Community discussions revolve around potential subprime auto lending market risks and concerns about the company's financial health amidst high short interest. Some traders are noting potential connections between Carvana's debt restructuring and stock behavior to other companies that may have a similar trend.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital ($GLXY) is trending amid discussions about analyst target raises and a recent earnings report that showed strong performance, although some investors are concerned about the stock's price action following the announcement. Community members are debating whether to increase their positions, with some highlighting the company's potential in AI data centers and crypto, while others point to market manipulation. Additionally, investors are closely watching news regarding a market structure bill and potential impacts on the broader crypto sector.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

NBIS is trending downwards, prompting community debate about whether it's a buying opportunity or a sign of deeper issues within the AI data center sector, despite a recent strategic investment in its autonomous driving unit. Discussions include speculation about institutional selling, potential support levels, and the overall health of AI-related stocks amid broader market fluctuations. Some investors remain confident in the company's fundamentals and long-term growth potential, citing the Microsoft contract and other ventures.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is trending amid discussions about its recent data release for its cystic fibrosis treatment, with community members debating whether the significant stock drop was an overreaction. Some investors are expressing confidence in the company's cash position and pipeline, while others are planning controlled exits or anticipating a price rebound. The stock is also being discussed in the context of broader market trends and potential short squeezes.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

ISRG is trending following positive earnings reports and raised guidance, which are driving optimism about the company's performance and future prospects. The community is discussing whether the recent surge is sustainable, with some suggesting a pullback is likely, while others point to strong fundamentals and potential for further gains. Bullish sentiment is fueled by the company's market position and growth in da Vinci procedures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unveiling 4 Analyst Insights On Genelux

Why Genelux Corporation (GNLX) Shares Are Down 40%

Genelux shares are trading lower by 40.7% during Friday's session. The company announced the pricing of an underwritten offering of 6.875 million shares.
read more...

Brokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)

Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on...

Genelux (NASDAQ:GNLX) Price Target Lowered to $32.00 at HC Wainwright

Genelux (NASDAQ:GNLX - Free Report) had its price objective reduced by HC Wainwright from $35.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a...

GNLX Stock Earnings: Genelux Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
GNLX stock results show that Genelux missed analyst estimates for earnings per share the fourth quarter of 2023.
The post GNLX Stock...

Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Continued active enrollment of Olvi-Vec in our pivotal Phase 3 OnPrime/GOG-3076 trial in platinum resistant/refractory ovarian cancer with topline results anticipated in 2H 2025 Initiation of...

Genelux reports Q4 EPS (25c), consensus (19c)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

LifeSteps Financial Inc. Purchases 2,191 Shares of Genelux Co. (NASDAQ:GNLX)

LifeSteps Financial Inc. boosted its position in Genelux Co. (NASDAQ:GNLX - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities...

12 titres de soins de sant  en mouvement lors de la session apr s-cl ture le 08/03/2024

Gagnants
L'action Genelux (NASDAQ:GNLX) a mont vendredi de 10,06% 7 dollars lors de la session after-market.
L'action Telesis Bio (NASDAQ:TBIO) a mont de 9,28% 0,60 dollars.
Le titre Estrella...

12 titoli sanitari in movimento, after-market del 08/03/2024

Titoli in rialzo
Le azioni di Genelux (NASDAQ:GNLX) hanno fatto segnare +10,06% a 7 dollari durante la sessione after-market di venerd .
Il titolo Telesis Bio (NASDAQ:TBIO) ha avuto un aumento del...

Genelux Corp. manufactures and markets drugs and virus strains solutions. It provides drug research, development, and clinical trial services for the healthcare industry. The company was founded by Aladar Szalay in 2001 and is headquartered in Westlake Village, CA.

Current Price	$6.24
Prev Close	$6.72
Open	$6.74
Dividend Yield	0.00%
50-Day Moving Average	$4.18
Beta	1.26
Avg. Volume	160,730.00
PE Ratio	-7.84

52-Week High	$6.85
52-Week Low	$1.99
Market Capitalization	$253.84M
EPS (Annual)	-$0.9497
Price to Book	10.50
Revenue Per Employee	$333.33
Enterprise Value/EBITDA	N/A

GNLX
Genelux Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GNLX News

GNLXGenelux Corp